T. Boulikas and M. Vougiouka, “Cisplatin and Platinum Drugs at the Molecular Level,” Oncology Reports, Vol. 10, No. 6, 2003, pp. 1663-1682.
has been cited by the following article:
TITLE: A DFT/ECP-Small Basis Set Modelling of Cisplatin: Molecular Structure and Vibrational Spectrum
AUTHORS: Nicolay I. Dodoff
KEYWORDS: Cisplatin; DFT Calculations; Basis Set; Effective Core Potential; Molecular Structure; Vibrational Analysis
JOURNAL NAME: Computational Molecular Bioscience, Vol.2 No.2, June 29, 2012
ABSTRACT: A DFT conformational and vibrational analysis of a single molecule of cisplatin (cis-[Pt(NH3)2Cl2]) was performed by means of PW91 functional and LANL08 ECP basis set for the Pt atom. 3-21G and 3-21G* Basis sets were used for the remaining atoms. All the initially chosen conformations were found to converge to the global minimum conformation of C2v symmetry with H atoms lying in the coordination plane and pointing to the Cl atoms. The computational results were compared with the newest experimental structural data and with the vibrational spectroscopic data for cisplatin, obtained by other workers. The chosen level of theory was found to describe satisfactory the molecular structure (r. m. s. of the relative deviations ≤ 6%) and the harmonic vibrational frequencies (r. m. s. of the relative deviations ≤ 5%) of cisplatin.